New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
ConditionAdenomyosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversité Catholique de Louvain
About this trial
Objectives:
To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods
Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease
Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Pre-menopausal
Disqualifiers
HIV or Hepatitis-positive
having participated in another clinical study in the 12 months prior to recruitment
presenting symptoms of endometriosis
Trial design
Treatments tested in this trial
- Circulating-mirna
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov